CorNova Inc. announced that it has received CE mark approval for its Valecor Platinum Coronary Stent System.
The Valecor Platinum is a next-generation cobalt-chromium bare-metal stent. Utilizing a novel ion-based implantation technology called Nanofusion™, the Valecor Platinum stent presents a pure platinum surface to both the lumen and artery wall to provide protection from less biocompatible components inherent in all medical-grade alloys. Platinum is known for its superior biocompatibility and biostability. In addition, the stent offers some of the thinnest struts available and a novel open cell design that maximizes flexibility and conformability, while causing minimal inflammation and tissue damage during deployment.
“The Valecor Platinum Coronary Stent System represents a major advancement over current offerings in the relatively undifferentiated $1 billion bare stent market,” said S. Eric Ryan, M.D., chairman and chief executive officer of CorNova. “Because of its highly biocompatible platinum surface and its novel open cell design, it has shown superior anti-restentotic performance compared to leading bare metal stents in preclinical studies.”
Source: CorNova Inc.
published: June 24, 2009 in: Cardio, Companies, Products, Regulatory, Specialty